Breast cancer: muscle relaxation and guided visualization together reduce the fear of chemo, depression and rebellion in patients undergoing chemotherapy because of breast cancer, after half year was in the intervention group demonstrated better quality of life. It is apparent from two randomized trials. Article updated April 8, 2011
June 5, 2005: Source: Support Care Cancer. 2005 in April 1923, and Support Care Cancer. April 2002, 10 (3) :237-46. <Muscle relaxation and guided visualization together reduce the fear of chemo, depression and rebellion in patients undergoing chemotherapy for their breast cancer. After half year was in the intervention group demonstrated better quality of life than in the control group of 30 patients each. It was also noticeable that the group of paitënten that muscle relaxation and visualization were vomiting and nausea occurred much less detectable than the patients in the control group. Among abstract of the first genetic study is also a similar study one year earlier with similar results.
Efficacy of progressive muscle relaxation training and guided imagery in Reducing chemotherapy side effect in patients with breast cancer and in Improving Their Quality of Life.
Yoo HJ, Ahn SH, Kim SB, Kim WK, Han OS.
Department of Psychiatry, Asan Medical Center, University of Ulsan College of Medicine, # 388-1, Pungnap-dong Songpa-gu, 138-736, Seoul, South Korea, junhkl@hanafos.com.
GOALS: This study was designed to Assess the effectiveness of progressive muscle relaxation training (PMRT) and guided imagery (GI) in Reducing the anticipatory nausea and vomit (ANV) and post-chemotherapy nausea and vomit (PNV) or patients with breast cancer and to measure Their effects on the patients' quality of life (QoL).
PATIENT AND METHODS: Thirty chemotherapy-naïve patients with breast cancer randomized to Were the PMRT and GI group and 30 to the control group. Before EACH or six cycles of adjuvant chemotherapy, Administered Each patient had a self-report Multiple Affect Adjective Checklist (MAACL), and incidents of ANV and PNV for the first three days post chemotherapy Were recorded. Were All Patients Administered the Functional Assessment of Cancer Therapy-Breast (FACT-B) at baseline and after 3 and 6 months.
RESULTS: We found thats the PMRT and GI group was significantly less Anxious, depressive, and hostile Than the control group. Also we found thats the PMRT and GI group significantly less Experienced ANV and PNV And That 6 months after CT, the QoL of the PMRT and GI group was higher Than That of the control group. CONCLUSION: These results PMRT and GI Indicating That Were Both associated with improvements in the ANV and PNV and in the QoL of Patients with breast cancer.
PMID: 15856335 [PubMed - as supp song by publisher]
Support Care Cancer. April 2002, 10 (3) :237-46.
The effectiveness of progressive muscle relaxation training in managing chemotherapy-induced nausea and vomit in Chinese breast cancer patients: a randomized trial.
Molassiotis A, Yung HP, Yam BM, Chan FY, Mok TS.
University of Nottingham, School of Nursing, A Floor, Medical School, Queen's Medical Centre, Nottingham, NG7 2UH, UK. Alexander.Molassiotis @ nottingham.ac.uk
This study was a randomized controlled trial designed to Assess the effectiveness of progressive muscle relaxation training (PMRT) in the clinical management of chemotherapy-related nausea and vomit as an adjuvant Accompanying Pharmacological intervention to antiemetic treatment (metoclopramide and dexamethasone iv). Seventy-one chemotherapy-naive breast cancer patients and an outpatient oncology unit of a university hospital in Hong Kong participated, with 38 subjects randomized to the experimental group and 33 to the control group. The intervention included the use of PMRT 1 h before chemotherapy was Administered and daily there after for another 5 days (for a total of six sessions PMRT). Each session lasted for 25 minutes and was followed by 5 minutes or imagery techniques. The Instruments Used for data collection included the Chinese versions of the Profile of Mood States and the State-Trait Anxiety Inventory (Measured before chemotherapy and then at day 7 and day 14 after chemotherapy), and the Morrow Assessment of Nausea and Vomit Scale, Which Used daily it was for the first 7 days post-chemotherapy. The use of PMRT Decreased considerably the duration of nausea and vomit in the experimental group compared with the control group (P <0.05), whereas there Were Trends Toward a lower frequency of nausea and vomit (P = 0.07 and P = 0.08 respectively). Neither nausea nor vomit differed in intensity Between the two groups. The significant effects Were Mainly clear on the first 4 days post-chemotherapy, When Were differences statistically significant. Although there was a significantly less severe overall mood Disturbance in the experimental group over time (P <0.05), this did not apply "in the case of anxiety. Such Findings suggest PMRT That is a technique to complement Useful adjuvant antiemetic for chemotherapy-induced nausea and vomit And That Such incorporation or interventions in the care plan can-Enhancethe standards of care of cancer patients who experience side effects of chemotherapy. Publication Types:
Clinical Trial
Randomized Controlled Trial
PMID: 11904789 [PubMed - indexed for MEDLINE]




